Bookmark
Forward
Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs.
Christina Kaiser Marko, Joan W Miller
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2021
Sizes of these terms reflect their relevance to your search.
The development of photodynamic therapy and anti-vascular endothelial growth factor agents have revolutionized the treatment of retinal diseases, transforming the retina subspecialty by ushering in an age of pharmacological treatments for a wide range of diseases, including age-related macular degeneration (AMD).
Citation
Christina Kaiser Marko, Joan W Miller.
Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
2021;49(1):19-24
Mesh Tags
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Aptamers, Nucleotide
Humans
Photochemotherapy
Ranibizumab
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Research
Research Support as Topic
Retinal Diseases
Translational Medical Research
Vascular Endothelial Growth Factor A
Substances
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Aptamers, Nucleotide
Recombinant Fusion Proteins
Vascular Endothelial Growth Factor A
aflibercept
pegaptanib
Receptors, Vascular Endothelial Growth Factor
brolucizumab
Ranibizumab
PMID: 33966647
View Full Text